Shares of K-V Pharmaceutical (KV.A +16.9%) soar after rival Columbia Laboratories' preterm birth...

|By:, SA News Editor

Shares of K-V Pharmaceutical (KV.A +16.9%) soar after rival Columbia Laboratories' preterm birth gel is deemed "not effective" by the FDA. Also showing some action related to the news is Watson Pharmaceuticals (WPI -2.6%).